ZHG-63809-83691

2 vaccinations 14 coded responses 22 check-ins 14 free-text entries 12 call cases

Sex: Female
Age at first dose: 31-35
ZIP prefix: 193 / PA
Registered: 2021-01-13

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-13
Registered in v-safe
2021-01-13
Dose 1 — Pfizer-BioNTech
2021-01-13
Health check-in — day 0, dose 1
Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-01-13
Report sent to call center — day 0, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-14
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-01-14
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-15
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Joint pains, Abdominal pain

Adult check-in
2021-01-17
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-20
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-27
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-02-03
Dose 2 — Pfizer-BioNTech
2021-02-03
Health check-in — day 0, dose 2
Feeling: Fair · Site: Itching · Headache

Adult check-in
2021-02-04
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Itching · Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-02-05
Survey response — days 1–6 daily, dose 2
MedDRA: Dyspnoea, Neuralgia, Tachycardia — Feeling: Poor · Site: Pain, Itching · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Shortness of breath, tachycardia, nerve pain in arm of injection

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-06
Survey response — days 1–6 daily, dose 2
MedDRA: Dyspnoea, Tachycardia — Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Joint pains, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Free text: Shortness of breath (moderate), tachycardia (moderate)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-07
Survey response — days 1–6 daily, dose 2
MedDRA: Dyspnoea, Tachycardia — Feeling: Poor · Site: Redness, Swelling · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Free text: Shortness of breath (moderate), tachycardia (moderate)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-08
Survey response — days 1–6 daily, dose 2
MedDRA: Dyspnoea, Tachycardia — Feeling: Poor · Site: Redness, Itching · Joint pains, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Free text: Shortness of breath (moderate), tachycardia (moderate)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-09
Survey response — days 1–6 daily, dose 2
MedDRA: Dyspnoea, Palpitations, Tachycardia — Feeling: Poor · Joint pains, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Shortness of breath (moderate), tachycardia (moderate), heart palpitations

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-09
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-10
Survey response — day 7, dose 2
MedDRA: Dyspnoea, Palpitations, Tachycardia — Feeling: Poor · Joint pains, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Shortness of breath (moderate), tachycardia (moderate), heart palpitations

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-10
Report sent to call center — day 7, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-17
Survey response — day 14, dose 2
MedDRA: Dyspnoea, Hypertension, Hypoxia, Office visit, Palpitations, Tachycardia — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Symptoms: Ongoing dyspnea, tachycardia, hypertension, intermittent hypoxia, heart palpitations · Healthcare visit (other): Cardiology consultation

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-17
Report sent to call center — day 14, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-24
Survey response — day 21, dose 2
MedDRA: Dyspnoea, Hypoxia, Palpitations, Tachycardia — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Still continue to have shortness of breath, tachycardia, heart palpitations, and intermittent hypoxia.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-24
Report sent to call center — day 21, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-03-04
Survey response — day 28, dose 2
MedDRA: Blood disorder, Chest discomfort, Dizziness, Dyspnoea, Hypertension, Hypoxia, Muscular weakness, Tachycardia — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Blood pooling in hands and feet, lightheadedness, orthostatic tachycardia, weakness in legs, chest pressure, sustained shortness of breath, hypertension, and intermittent hypoxia (being worked up for POTS caused by the vaccine)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-04
Report sent to call center — day 28, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-03-10
Survey response — day 35, dose 2
MedDRA: Blood disorder, Dizziness, Dyspnoea, Hypertension, Hypoxia, Muscular weakness, Tachycardia — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Continued shortness of breath, orthostatic tachycardia, lightheadedness, intermittent hypoxia, hypertension, blood pooling in hands and feet, weakness of lower extremities, and heart palpitations (being worked up for POTS caused by the vaccine)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-10
Report sent to call center — day 35, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-03-17
Survey response — day 42, dose 2
MedDRA: Chest pain, Dizziness, Dyspnoea, Fatigue, Hypertension, Palpitations, Peripheral venous disease, Postural orthostatic tachycardia syndrome — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Persistent shortness of breath, orthostatic tachycardia, hypertension, chest pain, lightheadness, and exhaustion. Still have venous pooling and heart palpitations. I have been diagnosed with POTS - cause is believed to be the vaccine.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-17
Report sent to call center — day 42, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-05-05
Survey response — 3 months, dose 2
MedDRA: Dyspnoea, Muscular weakness — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Leg weakness when I stand for more than a few minutes at a time. Worsening shortness of breath. I had a positive tilt table test that confirmed POTS. Doctors believe I developed POTS from the vaccine.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-05
Report sent to call center — 3 months, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-15
Call 1 — Left Voicemail
2021-08-04
Survey response — 6 months, dose 2
MedDRA: Dyspnoea, Flushing, Hypersensitivity, Mast cell activation syndrome, Postural orthostatic tachycardia syndrome, Pruritus, Rash, Urticaria — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Continue to have POTS symptoms, now have symptoms of mast cell activation syndrome - constant rashes, itching, new onset allergies, flushing, intermittent hives, shortness of breath

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-08-04
Report sent to call center — 6 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-11-04
Call 1 — Left Voicemail
2022-02-03
Survey response — 12 months, dose 2
MedDRA: Magnetic resonance imaging abnormal, Mast cell activation syndrome, Postural orthostatic tachycardia syndrome — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Myocarditis positive via MRI; mast cell activation syndrome; continue to have POTS

MedDRA releases: 2024-11 · check-in free text available
2022-02-03
Report sent to call center — 12 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-02-04
Call 1 — Requested Callback
2022-02-07
Call successful
Participant prefers to complete VAERS report online

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-13	Pfizer-BioNTech
2	2021-02-03	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-01-13	priority 2/3
2021-01-14	priority 2/3
2021-02-09	Successful	Participant prefers to complete VAERS report online
2021-02-10	Successful	Participant prefers to complete VAERS report online
2021-02-17	Successful	Participant prefers to complete VAERS report online
2021-02-24	Successful	Participant prefers to complete VAERS report online
2021-03-04	Successful	Participant prefers to complete VAERS report online
2021-03-10	Successful	Participant prefers to complete VAERS report online
2021-03-17	Successful	Participant prefers to complete VAERS report online
2021-05-05	Successful	Participant prefers to complete VAERS report online
2021-08-04	Successful	Participant prefers to complete VAERS report online
2022-02-03	Successful 2022-02-07	Participant prefers to complete VAERS report online

Free text

Release 3 — days 1–6 daily, dose 2

2021-02-05

Systemic reaction (other): Shortness of breath, tachycardia, nerve pain in arm of injection

2021-02-06

Systemic reaction (other): Shortness of breath (moderate), tachycardia (moderate)

2021-02-07

Systemic reaction (other): Shortness of breath (moderate), tachycardia (moderate)

2021-02-08

Systemic reaction (other): Shortness of breath (moderate), tachycardia (moderate)

2021-02-09

Systemic reaction (other): Shortness of breath (moderate), tachycardia (moderate), heart palpitations

Release 4 — day 7, dose 2

2021-02-10

Systemic reaction (other): Shortness of breath (moderate), tachycardia (moderate), heart palpitations

Release 4 — day 14, dose 2

2021-02-17

Symptoms: Ongoing dyspnea, tachycardia, hypertension, intermittent hypoxia, heart palpitations

Healthcare visit (other): Cardiology consultation

Release 4 — day 21, dose 2

2021-02-24

Symptoms: Still continue to have shortness of breath, tachycardia, heart palpitations, and intermittent hypoxia.

Release 5 — day 28, dose 2

2021-03-04

Symptoms: Blood pooling in hands and feet, lightheadedness, orthostatic tachycardia, weakness in legs, chest pressure, sustained shortness of breath, hypertension, and intermittent hypoxia (being worked up for POTS caused by the vaccine)

Release 5 — day 35, dose 2

2021-03-10

Symptoms: Continued shortness of breath, orthostatic tachycardia, lightheadedness, intermittent hypoxia, hypertension, blood pooling in hands and feet, weakness of lower extremities, and heart palpitations (being worked up for POTS caused by the vaccine)

Release 5 — day 42, dose 2

2021-03-17

Symptoms: Persistent shortness of breath, orthostatic tachycardia, hypertension, chest pain, lightheadness, and exhaustion. Still have venous pooling and heart palpitations. I have been diagnosed with POTS - cause is believed to be the vaccine.

Release 8 — 3 months, dose 2

2021-05-05

Symptoms: Leg weakness when I stand for more than a few minutes at a time. Worsening shortness of breath. I had a positive tilt table test that confirmed POTS. Doctors believe I developed POTS from the vaccine.

Release 9 — 6 months, dose 2

2021-08-04

Symptoms: Continue to have POTS symptoms, now have symptoms of mast cell activation syndrome - constant rashes, itching, new onset allergies, flushing, intermittent hives, shortness of breath

Release 11 — 12 months, dose 2

2022-02-03

Symptoms: Myocarditis positive via MRI; mast cell activation syndrome; continue to have POTS

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	✓	✓	✓
SD	Blood disorder	✓	✓	✓
SD	Chest discomfort	✓	✓	✓
SD	Chest pain	✓	✓	✓
SD	Dizziness	✓	✓	✓
SD	Dyspnoea	✓	✓	✓
SD	Fatigue	✓	✓	✓
SD	Flushing	✓	·	✓
SD	Hypersensitivity	✓	·	✓
SD	Hypertension	✓	✓	✓
SD	Hypoxia	✓	✓	✓
SD	Magnetic resonance imaging abnormal	·	·	✓
SD	Mast cell activation syndrome	✓	·	✓
SD	Muscular weakness	✓	✓	✓
SD	Palpitations	✓	✓	✓
SD	Peripheral venous disease	✓	✓	✓
SD	Postural orthostatic tachycardia syndrome	✓	✓	✓
SD	Pruritus	✓	·	✓
SD	Rash	✓	·	✓
SD	Tachycardia	✓	✓	✓
SD	Urticaria	✓	·	✓
SRO	Dyspnoea	✓	✓	✓
SRO	Neuralgia	✓	✓	✓
SRO	Palpitations	✓	✓	✓
SRO	Tachycardia	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release